Prescription Drug Cost Containment Act of 1992

[AI summary unavailable — showing source text] Prescription Drug Cost Containment Act of 1992 - Amends the Internal Revenue Code to require, in the case of any manufacturer of single source drugs or innovator multiple source drugs, a reduction in the Puerto Rico and possession tax credit according to a specified formula involving the amount of the manufacturer's wages paid to eligible employees in Puerto Rico, the sales of the drug, and price increases. Directs the Secretary of Health and Human Services to establish at least 15 five-year demonstration projects to determine the impact on: (1) cost, quality of care, and access to prescription drugs of developing, in the area of each project, a Medicare (title XVIII of the Social Security Act) outpatient prescription drug benefit using various forms of benefit design and reimbursement policies; and (2) cost and quality of care of extending coverage of outpatient prescription drugs to Medicare beneficiaries served by community health centers. Sets forth additional purposes for at least some of the projects. Requires a project to provide for coverage of all drugs and biologicals approved by the Federal Food and Drug Administration and all medically accepted indications of the drugs.…